Toshimitsu Yamaoka

Transactivation of EGF receptor and ErbB2 protects intestinal epithelial cells from TNF-induced apoptosis

Toshimitsu Yamaoka, Hanwei Cao, Stuart Hobbs et al. · Proceedings of the National Academy of Sciences · 2008 · 109 citations · Full text

Life Sciences, Cell Biology, Pathobiology +17

IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-α and IL-1β

Masayuki Iyoda, Takanori Shibata, Mio Kawaguchi et al. · American Journal of Physiology-Renal Physiology · 2009 · 91 citations

Life Sciences, Cell Biology, Immunology +13

Relationship of Circulating Tumor Cells to the Effectiveness of Cytotoxic Chemotherapy in Patients With Metastatic Non-Small-Cell Lung Cancer

Takashi Hirose, Yasunori Murata, Yasunari Oki et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2012 · 65 citations · Full text

Medicine, Oncology, Pharmacology +16

<i>KRAS</i> and <i>EGFR</i> Amplifications Mediate Resistance to Rociletinib and Osimertinib in Acquired Afatinib-Resistant NSCLC Harboring Exon 19 Deletion/T790M in <i>EGFR</i>

Kaori Nakatani, Toshimitsu Yamaoka, Motoi Ohba et al. · Molecular Cancer Therapeutics · 2018 · 49 citations

Medicine, Oncology, Pharmacology +17

Distinct Afatinib Resistance Mechanisms Identified in Lung Adenocarcinoma Harboring an EGFR Mutation

Toshimitsu Yamaoka, Tohru Ohmori, Motoi Ohba et al. · Molecular Cancer Research · 2017 · 47 citations · Full text

Medicine, Oncology, Pharmacology +16